×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
CVS Pharmacy® announces new simplified loyalty experience
Clarivate introduces the new OFF-X™ platform for preclinical and clinical safety intelligence
30 Jul 2024
Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the
...
FDA Approves Myhibbin™ by Azurity Pharmaceuticals, Inc., a Mycophenolate Mofetil Oral Suspension
Biosyngen's BRG01 gets FDA approval for Phase II clinical trial.
Scientific article highlights Namodenoson as promising for advanced liver cancer and MASH
Genentech to Reintroduce Susvimo for Wet Age-related Macular Degeneration (AMD) Treatment
FDA Grants KORU Medical Systems 510(k) Clearance for RYSTIGGO® Delivery via FreedomEDGE® Infusion System
By
KORU Medical Systems, Inc.
KORU Medical Systems, Inc.
02 Feb 2026
Tonix Pharmaceuticals presented Phase 3 RESILIENT data on TONMYA™ (cyclobenzaprine HCl sublingual tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
By
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp.
30 Jan 2026
China approves Libevitug, first-in-class therapy for hepatitis D
By
Huahui Health Ltd.
Huahui Health Ltd.
28 Jan 2026
DARZALEX FASPRO® quadruplet approved in U.S. for transplant-ineligible multiple myeloma patients
By
Johnson & Johnson
Johnson & Johnson
27 Jan 2026
Correction — Privo Technologies
By
Privo Technologies
Privo Technologies
26 Jan 2026
HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline
By
HanchorBio Inc.
HanchorBio Inc.
26 Jan 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Isotopia collaborates with LIVEKIDNEY.BIO, marking a breakthrough in lupus treatment advancements
By
Isotopia
Dec 12
Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025
By
Cognito Therapeutics
Apr 02
Paragonix Celebrates a Major Milestone: 100 Kidney Transplants Powered by the FDA-Cleared KidneyVault™ System
By
Paragonix Technologies
Apr 21
February
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
